Altered HLA-A2-Restricted TP53 Epitope Induces Specific CTL Cytotoxicity against Hepatocellular Carcinoma

Researchers detected widespread expression of shared TP53-Y220C neoantigen in HCC with low affinity and low stability of binding to HLA-A0201 molecules.